Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

Clinical trial NCT01284062 · COMPLETED

Trial details

NCT number: NCT01284062
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2011-03-01
Primary completion: 2013-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.